Age-related macular degeneration (AMD) is a multifactorial neurodegenerative disorder. Although molecular mechanisms remain elusive, deficits in autophagy have been associated with AMD. Here we show that deficiency of calcium and integrin binding protein 2 (CIB2) in mice, leads to age-related pathologies, including sub-retinal pigment epithelium (RPE) deposits, marked accumulation of drusen markers APOE, C3, Aβ, and esterified cholesterol, and impaired visual function, which can be rescued using exogenous retinoids. Cib2 mutant mice exhibit reduced lysosomal capacity and autophagic clearance, and increased mTORC1 signaling—a negative regulator of autophagy. We observe concordant molecular deficits in dry-AMD RPE/choroid post-mortem human tissues. Mechanistically, CIB2 negatively regulates mTORC1 by preferentially binding to ‘nucleotide empty’ or inactive GDP-loaded Rheb. Upregulated mTORC1 signaling has been implicated in lymphangioleiomyomatosis (LAM) cancer. Over-expressing CIB2 in LAM patient-derived fibroblasts downregulates hyperactive mTORC1 signaling. Thus, our findings have significant implications for treatment of AMD and other mTORC1 hyperactivity-associated disorders.
Rod and cone photoreceptors (PR), are highly specialized neurons, and serve as the site of signal transduction where irradiant light is converted into neuronal signals in the eye. PR outer segments (OS) are dedicated to phototransduction, however, they depend heavily on support from the retinal pigment epithelium (RPE), a single-layer of polarized cobblestone-shaped post-mitotic cells. RPE has multiple functions essential to normal vision, such as absorbing excess light, regenerating vitamin A-derived chromophores, and shuttling nutrients and metabolites from the sub-retinal space to the PR1. RPE supports the PR and hence vision by fulfilling several critical functions, including non-canonical autophagy or LC3-associated phagocytosis (LAP) of PR outer segments1,2. Likewise, macroautophagy (henceforth autophagy) is a catabolic process, which removes cellular debris, damaged/aged organelles, and shares many features with LAP. Autophagy is an essential process for all cells, but its function is especially notable in post-mitotic cells such as the RPE2 that have the highest life-long phagocytic load of any cell-type in the body.
Growing evidence suggests that RPE dysfunction, specifically in OS digestion and clearance, leads to age-related photoreceptor dysfunction without gross retinal degeneration2,3,4. For instance, RPE-specific deletion of ATG5, caveolin-1, or the β-crystallin protein leads to the impaired digestion of OS but does not cause gross retinal degeneration. However, the PR function (measured by electroretinography (ERG)) is substantially impaired2,3,4. Further, phagocytosis/ autophagy defects have been implicated in the dry form of age-related macular degeneration (AMD), a progressive degenerative disease of the macula, a specialized region of the retina responsible for daytime vision5. AMD often causes central vision loss and irreversible blindness, and affects 10% of the population aged 65-75 years and 25% of those aged ≥75 years. By 2050, its prevalence is expected to increase by 50%6,7. AMD is categorized as either “wet” (associated with choroidal neovascularization) or “dry” (associated with atrophy and progressive thinning of retinal layers). Dry AMD occurs in ~90% of the cases and can cause permanent vision loss if left untreated8.
Besides AMD, deficits in autophagy are linked to lifespan and several diseases such as Alzheimer’s, Parkinson’s, certain cancers, and metabolic disorders amongst others9,10,11. The mechanistic target of rapamycin complex 1 (mTORC1) is a well-established negative regulator of autophagy. mTORC1 also integrates nutrient and growth factors via its nutrient-sensing arm and tuberous sclerosis complex (TSC) complex, respectively12,13. TSC complex (consisting of TSC1, TSC2, and TBC1D7) directly regulates the small GTPase, Rheb (Ras homolog enriched in brain)14. GTP-bound Rheb is a potent and obligate activator of mTORC1 that acts via allosterically realigning the kinase active site of mTORC115. Aberrant mTORC1 signaling is also implicated in aging, cancers, obesity, and Alzheimer’s amongst others16. Therefore, deciphering the molecular regulators of autophagy and the mTORC1 pathway has significant ramifications for the fundamental cellular aging process and the etiology of autophagy-related disorders.
We previously identified that CIB2 impairment was associated with deafness and/or vision deficits in humans, zebrafish, and drosophila17. Downregulation of cib2 in drosophila significantly reduces photoresponse amplitudes and causes light-dependent retinal degeneration17. However, the molecular mechanism of such CIB2-associated vision loss remains unknown. Here, we show that the ablation of CIB2, specifically in the RPE, causes an age-related phenotype in mice and dysregulation of phagolysosomal processing of OS. Further, RPE-specific ablation of CIB2 leads to dysregulation of mTORC1 and autophagy. Our interaction studies reveal the preferential binding of CIB2 to the inactive state of Rheb, which then acts as a negative regulator of mTORC1.
Loss of CIB2 leads to age-related PR dysfunction and RPE pathology
Within the retina, CIB2 is expressed in the RPE, PRs, and certain ganglion cells (Supplementary Fig. 1a–g). To determine the exact function of CIB2 in the mammalian retina, we used Cib2tm1a mutant mice (Fig. 1a, Cib2KO henceforth)18 that lack CIB2 in the RPE (Supplementary Fig. 1f) as well as other retinal layers. Non-invasive in vivo scotopic full-field ERGs (illustrated in Fig. 1b), which preferentially analyze rod PR function, revealed no difference in a-wave (derived primarily from the photoreceptor layer) or b-wave (derived from the inner retina, predominantly Müller and outer nuclear bipolar cells) amplitudes in 1-month-old Cib2-deficient mice. However, at 3, 6, and 9 months, both Cib2KO/+ and Cib2KO/KO mice exhibited similar age-related declines (~20–30%) in both a- and b-wave amplitudes, as compared with those of wild type (WT) mice (Fig. 1c). However, the declines were not demonstrated in latency or oscillatory potential, suggesting the inner retinal function was not impacted (Supplementary Fig. 2a, c). In contrast, the b-wave amplitude of the photopic ERG, which evaluates cone PRs, was similar across all three genotypes (Supplementary Fig. 2b). These results suggest that both haploinsufficiency and complete loss of CIB2 leads to rod PR dysfunction in mice.
To determine whether corresponding anatomical changes occurred with progressive loss of PR function, we evaluated the morphology of the retina in 2 and 8- to 9-months-old Cib2-deficient mice. Light microscopy-based morphometric analysis of the specific retinal strata revealed no significant differences in Cib2KO/+ and Cib2KO/KO compared to those of WT mice at either age (Supplementary Fig. 2d, e). However, at the transmission electron microscopic (TEM) level, we observed vacuoles with undigested membranous material and loss of basal infoldings in the RPE of Cib2KO/+ and Cib2KO/KO mice, but not in age-matched WT mice (Fig. 1d). Staining with the neutral lipid tracer BODIPYTM 493/503 revealed twofold more lipid droplets in the RPE of aged Cib2KO/+ and Cib2KO/KO mice (Fig. 1e, f). Together, these results suggest that loss of CIB2 causes excessive lipid accumulation in RPE and is associated with progressive rod PR dysfunction.
Selective ablation of CIB2 in RPE but not in PRs recapitulates retinal pathophysiology
In the mammalian retina, PRs and RPE are codependent, therefore, the functional impairment of one layer negatively impacts the other2,3,4,19. To pinpoint the anatomical site of age-related rod PR dysfunction seen in global Cib2-deficient mice, we generated two cell type-specific mutant strains, in which Cib2 expression was ablated either in rod PR (designated PR-Cre+) using the rod PR-specific rhodopsin–iCre7520, or in the RPE (designated RPE-Cre+) using the RPE-specific Vmd2 promoter21 (Fig. 1a and “Methods” section). ERG analyses revealed that the RPE-specific Cib2KO (Cib2flox/flox; RPE-Cre+ and Cib2flox/+; RPE-Cre+) mice had reduced ERG amplitudes compared to the control mice (Cib2+/+; RPE-Cre+) as early as 3 months of age. Similar to Cib2 global knockout mice, ERG amplitudes declined even further with age (Fig. 2a). In contrast, we found no differences in either a- or b-wave amplitudes with PR-specific Cib2KO (Cib2flox/flox; PR-Cre+ and Cib2flox/+; PR-Cre+) mice compared to control mice at any tested age (Fig. 2b and Supplementary Fig. 3a, b). Taken together, the retinal functional and morphological analyses in three mutant strains suggest that rod PR dysfunction occurs secondary to the loss of CIB2 function in RPE but not in rod PRs.
With respect to the thickness of RPE- and PR-specific Cib2KO mice retinal strata, we found no morphometric differences (Supplementary Fig. 3c, d), however, TEM revealed sub-RPE deposits in RPE-specific Cib2KO mice (Fig. 2c) that were absent in PR-specific mutants (Supplementary Fig. 3e). As seen in Cib2 global knockout mice, we also found the presence of an increased amount of lipid droplets in the RPE of RPE-specific Cib2KO mice (Fig. 2d, e). We further confirmed the presence of these lipid droplets in 9- to 10-months-old RPE-specific mutant mice by staining frozen transverse sections with Oil Red O (Fig. 3a). Lastly, we also found increased filipin staining specifically under RPE, which revealed the accumulation of both unesterified and esterified cholesterol (Fig. 3b). Esterified cholesterol, in particular, has been shown to accumulate in drusen and deposits in the Bruch’s membrane in humans suffering with dry AMD22.
Molecular characterization of sub-RPE deposits in Cib2-deficient mice
As presented in humans, AMD is a progressive, age-related, and degenerative disease of the retina. AMD is categorized as either wet or dry, due to either choroidal neovascularization or progressive thinning of macula layers, respectively23. Sub-RPE drusen are a prominent feature observed in humans suffering with dry AMD24. Protein-level analysis of drusen found in dry AMD patients, revealed accumulation of proteins such as apolipoprotein E (APOE)25, β-Amyloid (aβ), and complement factor 3 (C3), a genetically validated AMD risk factor26,27,28. Meanwhile, a recent study showcased that the levels of LAMP2/CD107b (a lysosomal membrane protein) are reduced in AMD RPE/choroid tissues29. Observation of similar sub-RPE deposits in TEM micrographs in Cib2-mutant mice prompted us to investigate the molecular composition of the deposits. We found that in 9-to-10-months-old RPE-specific Cib2 mutant mice there was a marked accumulation of APOE, β-Amyloid (aβ), and C3 (Fig. 3c, d) below the RPE and reduced expression of LAMP2/CD107b within the RPE (Fig. 3e). Ultimately, our data shows that bonafide AMD drusen markers and lipid species are enriched in the sub-RPE deposits in Cib2-mutant mice, alluding to the potential role of CIB2 in human AMD.
Loss of CIB2 leads to dysregulated clearance of photoreceptor outer segments
Defects in the OS renewal process in mice can lead to the formation of vacuoles and an accumulation of lipids4, a phenotype similar to that presented in Cib2KO mice. We reasoned that a lack of CIB2 may lead to debris and vacuole formation in older mice (8–10 months) due to faulty phagolysosomal processing of the OS by the RPE early in life (2–4 months). We took advantage of the characteristic diurnal circadian nature of RPE-mediated OS phagocytosis to quantify engulfment (early after light onset) and digestion (rest of the day), by in situ quantification of phagosomes within the RPE, at specific times after light onset. The OS are composed of 50% lipids and 50% proteins, and rhodopsin constitutes about 80% of rod OS protein content. Thus, any rhodopsin found in the RPE is from phagocytosed OS and can be used as a marker to track the OS renewal process3,30. In situ, we found that counts of opsin-phagosomes in whole mounts of RPE/choroid 1 h after light onset, corresponding to the peak of OS engulfment, were similar in Cib2KO and WT mice, indicating that binding and engulfment of OS were unaffected by Cib2 deficiency (Fig. 4a, top panel and b). However, Cib2KO mice exhibited significantly higher numbers of opsin-phagosomes eight and twelve hours following the onset of light, representing slower phagolysosomal clearance (Fig. 4a, bottom panel and b and Supplementary Fig. 4a, b). The average diameters of opsin-phagosomes decreased in tandem with time from the onset of light-on in WT animals. On the other hand, the decreases in Cib2KO mice were delayed, further confirming that Cib2 deficiency leads to phagolysosomal dysfunction (Supplementary Fig. 4c). TEM imaging of 2-months-old mice retinae that were dissected eight hours after light onset revealed that Cib2KO/+ and Cib2KO/KO mice exhibited marked accumulation of improperly-digested remnants, lipid droplets fused with undigested material, and/or fused phago-melanosomes (Fig. 4c, d). Similar deficits were observed in RPE-specific Cib2KO mice 8 h after light onset (Fig. 4e–g).
Proper clearance of ingested OS requires optimally functioning lysosomal machinery. In the RPE, the aspartyl protease cathepsin D is essential for phagosome digestion3,31,32,33. Cathepsin D is translated as ~50 kD pro-cathepsin D and matures to its active form (~30 kDa) in the low-pH lysosomal milieu. RPE flat mounts ex vivo probed with BODIPY-pepstatin A, which binds specifically to mature-cathepsin D, showed a marked reduction of about 2.5 fold in indirectly stained lysosomes, and hence available mature-cathepsin D in Cib2KO/+, Cib2KO/KO, and RPE-specific Cib2KO mice (Fig. 5a–d and Supplementary Fig. 5a, 5b, left panel), but not in PR-specific Cib2KO mice (Fig. 5e and Supplementary Fig. 5b, right panel). Further, immunoblotting revealed markedly reduced levels of mature-cathepsin D, consistent with the BODIPY-pepstatin A labeling, LAMP-1, and ATG5-ATG12 complex in Cib2KO/KO mice, both one and twelve hours after light onset (Fig. 5f, g).
Complementary to the findings of Cib2-mutant mice, over-expressing CIB2 in RPE-J cells increased LAMP-1 and ATG5-ATG12 complex proteins levels (Supplementary Fig. 5c, d). To assess whether CIB2 overexpression has a functional impact, we performed in vitro pulse-chase phagocytosis assays3 followed by immunoblotting for opsin in RPE-J cells (schematic—Supplementary Fig. 5e, left panel). Again, in agreement with our findings in mice, we detected similar opsin levels bound initially (pulse-0 h) with control or CIB2 overexpression. However, 6 h later, corresponding to the digestion phase, we found less opsin in cells with excessive CIB2, suggesting that CIB2 overexpression alone suffices to boost phagolysosomal digestion (Supplementary Fig. 5e, f). Collectively, our results suggest that lack of CIB2, specifically in the RPE, causes defects in LC3-associated phagocytosis and reduced levels of autophagy proteins such as ATG5-12, in the RPE (Fig. 6a), whereas transient CIB2 overexpression augments OS clearance.
Loss of CIB2 leads to autophagic clearance defects due to hyperactive mTORC1 signaling
Non-canonical autophagy such as phagolysosomal OS processing shares many aspects and proteins with canonical autophagy2. Hence, we reasoned that autophagy is impaired in Cib2-mutant mice. When autophagy is fully functional, the levels of autophagosome membrane protein LC3-II increase, while those of the autophagosome marker protein p62/SQSTM1 decrease in concert, due to specific digestion within the autolysosome. When autophagy is faulty, levels of both p62/SQSTM1 and LC3-II increase34. Thus, to assess the functionality, we evaluated the levels of p62/SQSTM1 and LC3-II in Cib2-mutant mice after inducing autophagy.
First, to induce autophagy in vivo, we fasted 2–3-months-old animals for 24 h and collected the RPE/choroid. Immunoblots of RPE/choroid lysates from autophagy induced Cib2KO/+ and Cib2KO/KO mice showed that their p62/SQSTM1 and LC3-II levels doubled compared to those in WT age-matched controls (Fig. 6b, c). To assess if autophagy is dysregulated over time, we assessed the LC3-II and p62/SQSTM1 levels in aged mice, fed ad libitum. We observed a 2–3-fold increase in both LC3-II and p62/SQSTM1 levels, which suggests that loss of CIB2 leads to early as well as age-related autophagy deficits (supplementary Fig. 6a, b). LC3-I is a cytosolic protein but when lipidated with a phosphatidylethanolamine adduct (LC3-II form) localizes to the growing auto/phagosome membrane, and thus can be used as a reliable readout for the dynamic autophagic process2,4,34. RPE/choroid whole mounts, ex vivo, were incubated overnight with DMSO (control) or bafilomycin A1, which blocks autophagosome fusion with lysosomes, and the relative ratio of LC3-II (bafilomycin A1/DMSO) was assessed with immunoblotting34. We found a ~50% reduction in relative LC3 flux in RPE-specific Cib2KO mice (Supplementary Fig. 6c, d). In addition, over-expressing CIB2 in RPE-J cells markedly increased relative LC3 flux in the presence of bafilomycin A1. The mTORC1 inhibitor rapamycin similarly elevated LC3-II levels (Supplementary Fig. 6e, f). These results strongly support the role of CIB2 in the clearance of autophagosomes, without compromising autophagosome biogenesis.
Since mTORC1 is a known negative regulator of autophagy, we assessed the status of mTORC1 signaling in Cib2-mutant mice. First, we measured phospho-protein levels of the bonafide mTORC1 downstream targets 4E binding protein 1 (4E-BP1) and S6 kinase 1 (S6K1). RPE/choroid lysate immunoblots from mutant mice undergoing induced autophagy revealed an approximately 2-fold increase in 4E-BP1 and S6K1 phospho-protein levels, but we found no difference in levels of the mTORC2 downstream target phospho-AKT. (Fig. 6d, e). Our kinase assay using mice brain lysates, further confirm mTORC1 hyperactivity in Cib2-mutant mice (supplementary Fig. 6g). Next, we tested if CIB2 is a specific negative regulator of mTORC1, mTORC2, or both. For this purpose, we used HEK293 cells for two reasons: first, because the mTORC1 signaling pathway is well-established in these cells35, and secondly to expand CIB2 functions beyond the RPE. HEK293 cells over-expressing increasing amounts of CIB2 showed decreasing phosphorylation of the mTORC1 targets 4E-BP1, and ULK1. We found no changes in mTORC2-mediated phosphorylation of AKT (Fig. 6f). Together, these results suggest that CIB2 impacts autophagy, specifically by modulating mTORC1.
CIB2 forms a tripartite complex with Raptor-mTOR
To gain insights into the molecular mechanism of CIB2-mediated mTORC1 modulation, we assessed direct interactions between CIB2 and TSC1, TSC2, mTORC1-specific subunit Raptor, mTOR kinase, and Rheb, using a previously reported nanoscale pulldown 2.0 (NanoSPD) quantitative interaction assay36. NanoSPD utilizes a construct (nanoTRAP) consisting of GFP nanobody fused with the heavy meromyosin (HMM domain) of myosin 10 (myo10HMM-GFP nanobody). This allows preferential migration of any GFP-tagged protein to the filopodia tips in the transfected cells36. As anticipated, GFP-hCIB2 (bait) migrated efficiently to filopodia in COS-7 cells only in the presence of the nanoTRAP. As control, we ruled out the interaction of HA-mCherry-Raptor or myc-mTOR with nanoTRAP and with GFP tag (Fig. 7a, d). Using NanoSPD assay, TSC1 and TSC2, the major proteins of the TSC complex directly regulating Rheb, did not show any co-accumulation with GFP-hCIB2 (Fig. 7c, d). In contrast, we found that Raptor, but not mTOR, interacts with CIB2. However, mTOR and CIB2 can form a tripartite complex in the presence of Raptor (Fig. 7b, d). We further confirmed the CIB2-Raptor interaction using co-immunoprecipitation (co-IP) assay (Fig. 7e).
mTORC1 is a cytosolic complex when starved of amino acids and nutrients. However, it localizes to the lysosomes in the presence of amino acid, nutrients, and growth factors12,13. We sought to assess whether the loss of CIB2 leads to aberrant localization of the mTORC1 complex. First, we generated adipose tissue-derived mesenchymal stem cells (MSCs) from WT and Cib2KO/KO mice (supplementary Fig. 7) to monitor the localization of the mTORC1 complex. In both WT and Cib2KO/KO MSCs mTOR was cytosolic in the absence of amino acids (Supplementary Fig. 8a). Next, we triggered lysosomal localization by adding amino acids in the media. In both WT and Cib2KO/KO MSCs, mTOR was co-localized with lysosomal marker LAMP, indicating that the loss of CIB2 did not affect the lysosomal targeting of mTOR trigged by amino acids (Supplementary Fig. 8a). Similarly, we observed no localization deficits in the absence and presence of other signaling factors such as insulin and glucose (Supplementary Fig. 8b, c). However, in the absence of CIB2, mTOR co-localized with LAMP-1 to a much greater extent, when Ca++ was chelated with EGTA (Supplementary Fig. 8d). In WT MSCs, we also assessed the co-location of CIB2 with TSC2. We found no significant co-localization between CIB2 and TSC2 under any of the conditions tested (supplementary Fig. 9a). These findings imply that CIB2 has a role in the Ca++-dependent regulation of mTORC1 complex localization in the lysosomes.
CIB2 negatively regulates mTORC1 via preferential binding to “nucleotide empty-” or GDP-Rheb
When we analyzed the co-localization of CIB2 with Rheb, we found significant overlap under all the conditions tested (supplementary Fig. 9b). To assess whether CIB2 actually directly interacts with Rheb we utilized the NanoSPD assay. Interestingly, NanoSPD revealed a direct interaction between CIB2 and Rheb (Fig. 8a, b), adding a new binding partner into the growing list of Rheb interactome37. CIB2 partnered uniquely with Rheb, but not with other Rheb-activators; including TSC complex and microspherule protein 1 (Supplementary Fig. 10a–c). Rheb is a 184 amino acid evolutionary conserved GTPase (Supplementary Fig. 11). GTP-bound Rheb acts as a potent and obligate activator of mTORC115. Hence, we next explored the impact of the nucleotide-binding state of Rheb on interaction with CIB2 through co-IP studies (Fig. 8c–f). For these studies, we used WT protein, Rheb harboring the Q64L variant that has increased GTP loading and partial resistance to GAP activity of TSC, and Rheb with S20N missense variant that has severely reduced GTP and GDP binding capacity (~1% of WT Rheb), essentially acting as a “nucleotide empty” variant38. Consistent with prior findings, we found reduced expression of Rheb-S20N variant protein (Fig. 8d – cell lysate, Supplementary Fig. 11d). In the co-IP assay, CIB2 bound preferentially to the S20N variant as compared to either the Rheb-WT or the Rheb-Q64L variant (Fig. 8d).
CIB2’s preferential binding to nucleotide reduced/empty state of Rheb was further validated by loading glutathione bead-immobilized HA-GST-Rheb (WT) with either GDP or non-cleavable GTPγS and adding CIB2 lysate (Supplementary Fig. 11b), and through analyzing additional mutagenic constructs (nucleotide-binding capacity summarized in Fig. 8c). Previously, a mutagenesis screen and subsequent targeted substitution of aspartic acid at position 60 (D60) to valine (V) or isoleucine (I) showed significantly diminished affinity to GTP but comparable GDP binding capacity as WT Rheb. Meanwhile, the D60K variant turned out to be a nucleotide empty variant39,40. In our co-IP studies, we found that CIB2 preferentially binds to, in order of binding strength, nucleotide empty D60K variant, than D60I and D60V (Fig. 8e).
Farnesylation of Rheb is essential for nucleotides loading and activation38. To explore the essentiality of Rheb-farnesylation for CIB2 coupling, we performed co-IP studies using the farnesylation deficient variant C181S, and Rheb with the last four amino acids deleted (Δ181–184), which was shown to be essential for proper loading of nucleotides38. We found significantly reduced CIB2 binding in the absence of Rheb-farnesylation (Fig. 8e, f). These findings were further confirmed by using the farnesyl transferase inhibitor, lonafarnib (Fig. 8f). Finally, as we observed CIB2 interaction both with Rheb and Raptor, which are also known to interact with each other41, we wondered if CIB2 impacts the interaction of Rheb with Raptor. However, no obvious effect on the binding of Rheb to Raptor in the presence of CIB2 was observed in co-IP assays, which suggests non-competing binding sites of Raptor and CIB2 with Rheb (Supplementary Fig. 11c). Taken together, our studies demonstrated that CIB2 modulates mTORC1 activity, and hence autophagy, by preferentially binding to nucleotide empty/GDP-Rheb (inactive form).
mTORC1 is also upregulated in RPE/choroid tissues from patients affected with AMD
Previous studies in mouse models2,3,4,42,43 and humans samples5,42,44 have shown that both non-canonical and canonical autophagy is essential for RPE function. In humans, AMD is characterized by drusen accumulation in the inner collagenous layer of Bruch’s membrane, RPE vacuolization, and accumulation of lipid deposits within the RPE, Bruch’s membrane, and elsewhere. Aging-associated lipid accumulation is further thought to hinder lipid degradation by phagolysosomes and autolysosomes in RPE, thereby exacerbating the accumulation of undigested lipids45, and this has been suggested as an important causative factor in dry AMD. Since our CIB2-deficient mice showed similar age-related RPE pathologies, we reasoned that upregulated mTORC1 signaling might be a contributing factor for the autophagy deficits seen in AMD patients as well. To test this, we evaluated RPE/choroid tissues bio-banked from human subjects affected with dry AMD (n = 8) along with age-matched control (n = 10) tissues (Supplemental Table 1). Consistent with observations made in primary RPE cell cultured from AMD patients5, autophagy was impaired in dry AMD RPE/choroid lysates, as exhibited by the accumulation of both p62/SQSTM1 and LC3. Further, dry AMD patients’ lysates exhibited reduced CIB2 expression, and higher levels of phosphorylated, but not of total protein levels, ULK1 and 4E-BP1 (Fig. 9a, b and Supplementary Fig. 12), indicating hyperactive mTORC1 signaling. These results demonstrate that similar to Cib2-mutant mice, dry AMD patients’ RPE/choroid tissue also has reduced CIB2 levels, hyperactive mTORC1 signaling accompanied by autophagy deficits.
Besides AMD (shown here), upregulated mTORC1 signaling is also implicated in aging, TSC, and cancers, including lymphangioleiomyomatosis (LAM). Further, TSC variants lead to RPE lesions in human patients46. The above studies demonstrated that CIB2 acts as a negative regulator of mTORC1, and hence, we reasoned that CIB2 overexpression may partially downregulate the hyperactivated mTORC1 signaling observed in TSC and LAM. To evaluate this, we utilized two different diseases models. First, a patient-derived cell line LAM-621 (LAM-associated renal angiomyolipoma) harboring a variant in TSC2 (p.Arg611Gln) rendering it unable to complex with TSC1, resulting in hyperactivated mTORC1 signaling47. LAM-621 cells over-expressing increasing amounts of CIB2, showed decreasing amounts of phosphorylated 4E-BP-1 and ULK1, but not AKT (Fig. 9c, left panel). Secondly, Tsc2KO/KO, p53KO/KO mouse embryonic fibroblasts (MEFs), similarly over-expressing CIB2, resulted in a reduction of mTORC1 but not mTORC2 targets (Fig. 9c, right panel). Taken together, we show that CIB2 preferentially binds to an inactive form of Rheb, thereby regulating mTORC1 activity. Aberrant mTORC1 activity leads to chronic autophagy deficits leading to RPE pathology and secondary photoreceptor dysfunction (Fig. 9d). Our findings signify that CIB2 can partially downregulate mTORC1, independently of the TSC complex, and thus potentiating it as a target for modulation of mTORC1 specifically.
Rescue of PR function in Cib2-mutant mice by evading the RPE- retinoid cycle
RPE is essential for the visual cycle regeneration of 11-cis retinal, the chromophore of photoreceptor opsins. Upon photon absorption, 11-cis retinal is photo-isomerized to all-trans retinal, thereby activating opsin and initiating the phototransduction cascade48,49. All-trans retinal is regenerated to 11-cis retinal, which is then recycled back to the photoreceptors via a series of transport and enzymatic steps, occurring primarily in the RPE (illustrated in Fig. 10a). The ERG deficits in Cib2 mutants without significant photoreceptor damage led us to investigate this key visual pathway. First, we quantified the absolute retinoid levels (11-cis oxime, all-trans oxime, retinyl esters, and A2E) within the retina or RPE/choroid in 2-to-3 months and 8-to-9-months-old Cib2KO/+, Cib2KO/KO. However, no significant differences were observed when compared to control age-matched WT mice (Supplementary Fig. 13a, b). We reasoned that the vacuoles observed in the RPE may partially sequester retinoids, rendering them unavailable to re-enter the PR. Therefore, we tested whether we could rescue the ERG defects via exogenous chromophore, thus bypassing the RPE visual cycle altogether. For these studies, we used two different treatment paradigms. First, we injected aged global Cib2KO (either heterozygous or homozygous) mice once with either 9-cis retinal (an analog of 11-cis retinal) or vehicle. Then, we assessed their visual function by ERG the following day, after dark adaptation. Treatment of Cib2KO mice with 9-cis retinal restored their ERG amplitudes to near WT levels with significant differences in scotopic a- and b-wave amplitudes as compared to vehicle-injected Cib2KO controls (Fig. 10b).
Second, to further assess the potential clinical translatability of exogenous retinoids, we employed an extended treatment paradigm following injection of 9-cis retinal in RPE-specific Cib2KO mice (Fig. 10c). We performed baseline ERGs on 8-months-old uninjected mice and found significant differences in ERG amplitudes in mutant mice compared to RPE-Cre + control mice (Fig. 10d). Two weeks after the first injection, we found significantly improved ERG amplitudes for RPE-specific mutant mice injected with 9-cis retinal. The ERG amplitudes of 9-cis retinal injected mice were essentially indistinguishable from those of vehicle-injected control mice. However, the rescue effect of exogenous retinoid was short-lived. By four weeks post-injection, the ERG amplitudes of 9-cis retinal injected RPE-specific mutant mice were substantially lower than control mice. To assess the medium-term efficacy of exogenous retinoid therapy, we extended the paradigm further by 1 month. Again, we saw an improvement in ERG amplitudes for mutant mice injected with 9-cis retinal two weeks after the second injection, but by four weeks, ERG amplitudes fell back to baseline levels (Fig. 10e). This suggested that short-term but reproducible improvement in ERG amplitudes is possible with this treatment. At the conclusion of treatment, TEM analysis of the RPE revealed vacuoles and/or sub-RPE deposits present in all three 9-cis retinal-treated RPE-specific Cib2KO mice, but not in vehicle-treated RPE-Cre + control mice (1 of 3) (Fig. 10f). The results strongly suggest that repeated exogenous retinoid treatment can rescue photoreceptor function temporarily yet reproducibly in Cib2-deficient mice by bypassing the RPE. Although, (as expected) this does not improve RPE pathophysiology.
This study highlights the crucial role of CIB2 in the regulation of phagolysosomal digestion of OS and the development of age-related phenotype in mice. CIB2 belongs to a family of proteins that includes four members (CIB1–CIB4). CIB proteins contain Ca2+/Mg2+ binding EF-hand domains, and binding of these ions leads to a conformational change and downstream effects, similar to the well-studied protein, calmodulin50,51. In recent years, the various developmental or functional roles of CIB2 have been elucidated in multiple organs, however, the precise tissue-specific mechanisms remain unclear. For instance, CIB2 is downregulated in ovarian cancer and associated with poor prognosis in ovarian cancer patients52. Previously, we and others reported on the essential function of CIB2 in the inner ear development and mechanotransduction of sound signal18,53,54. Furthermore, CIB2-deficient mice showed a small, but not statistically significant difference in ERG amplitude between heterozygous and homozygous mice, leading the authors to conclude that CIB2-deficient mice exhibit no retinal phenotype53. However, the main caveats of that study were use of only one intensity of light for retinal functional evaluation and the lack of instrumental WT controls53.
In this study, we used three different mutant mouse strains and found that both a complete loss (homozygous) and haploinsufficiency (heterozygous) of CIB2, specifically in RPE, leads to attenuated ERG amplitudes and development of age-related phenotype encapsulating several dry AMD features. The mutant mice from our study had fewer lysosomes, lysosomal and autophagy proteins, and defects in phagolysosomal clearance of OS. As OS phagosomes contain ~50% lipid, chronically delayed OS clearance causes accumulation of lipids. Confirming this trend, we found double the amount of neutral lipid droplets in the RPE in aged Cib2KO mice with a gradual accumulation of un-cleared lipids and proteins. Since RPE cells are post-mitotic these insults accumulate over time, resulting in an age-dependent RPE pathology and PR dysfunction. Earlier, genetic deletion of genes involved in clearance of ingested OS, specifically in the RPE, was found to lead to secondary photoreceptor functional defects2,3,4. Further, the RPE presents the largest source of electrical resistance for in vivo ERGs55, and hence the ERG changes we observed were likely caused by RPE dysfunction and subsequent pathology. Our PR- and RPE-specific Cib2 knockout data further support this conclusion.
The RPE-mediated OS non-inflammatory clearance process requires LC3-associated phagocytosis. Deficiency in LAP has been associated with various disorders such as SLE, multiple sclerosis, atherosclerosis, and AMD, amongst others56. It has proven quite challenging to study AMD, since mouse models of genetically validated targets do not recapitulate the human phenotype. Here, we show that global or RPE-specific lack of CIB2 recapitulates many aspects of the human AMD pathophysiology including sub-RPE deposits, and accumulation of APOE, C3, and aβ. Further, we found increased lipid droplets and esterified cholesterol, which is associated with drusen in humans and sub-RPE deposits in mouse models. Autophagy decreases with aging in several tissues including the RPE9,42,44. RPE cells cultured from AMD patients showed elevated numbers of autophagosomes, lipid droplets, aberrantly large lysosomes, and higher starvation-induced SQSTM1/p62 levels5. Consistent with these observations, we found an accumulation of both p62/SQSTM1 and LC3, suggesting aberrant autophagy in RPE/choroid samples from dry AMD patients. Concordant with our animal models, we also observed reduced levels of CIB2, and hyperactive mTORC1 in these human samples. Together, these data reconcile CIB2 levels, mTORC1 activity, autophagy, and their age-associated impact on the RPE maintenance and function in mice and humans.
mTORC1, the key negative regulator of autophagy, is cytosolic and in the presence of sufficient nutrients, it is recruited to the surface of the lysosomes12,13. GTP-loaded active Rheb allosterically realigns the kinase active site of mTORC1, and thus is a potent and obligate activator of mTORC1 on the surface of the lysosomes15. We found that CIB2 preferentially binds to, in order of binding strength, the nucleotide-empty form of Rheb followed by GDP-loaded inactive Rheb, and then GTP-loaded active Rheb. Our results here support the function of CIB2 as a “co-factor” to preferentially maintain Rheb in an inactive state. However, further biochemical studies will be needed to decipher the precise mechanism and stoichiometry of CIB2-Rheb and CIB2-Raptor interactions. Furthermore, since mTORC1 is downstream of AMP-activated protein kinase (AMPK), one of the main integrators of energy cues and a negative regulator of mTORC157, it would be interesting to assess whether CIB2 establishes any feedback mechanism between mTORC1 and AMPK pathways. Lastly, we also found differential regulation of mTOR localization upon Ca++ chelation in the CIB2-mutant mice (supplementary Fig. 8d), alluding to the potential role of CIB2 in intracellular Ca++ regulation, as was found for CIB150. Our current study establishes CIB2 at the intersection of autophagy, mTORC1 signaling, and visual function, thus providing fundamental knowledge that would be instrumental in gaining further mechanistic insights.
Besides AMD, a growing literature points to defects in autophagy, lysosomal functions, and mTORC1 signaling in aging and diverse neurodegenerative disorders with complex genetic architecture such as Alzheimer’s, autism, epilepsy, cancers, obesity, and heart diseases. Thus, identifying molecular targets that can be used to modulate or restore autophagy may offer new avenues for the treatment of such disorders58. Direct mTOR kinase inhibitors or rapamycin (and its analogs) have shown only limited success in dry AMD patient trials59,60, as chronic exposure to either class of compounds also leads to mTORC2 disassembly and affects cell survival61. Since direct mTOR inhibition is not a viable long-term strategy, there is intense efforts to discover drugs modulating the mTORC1 pathway by targeting other players of the pathway such as Rheb62. CIB2 is a small gene that can easily fit within the carrying capacity of AAV for in vivo delivery, supporting potential translatability via gene therapy. Moreover, autophagy is linked to lysosomal biogenesis via the transcription factor EB (TFEB) family, the lysosomal master transcription factor family (TFEB/ TEF3/ MiTF) via which mTORC1 controls lysosomal biogenesis63. The reduction of lysosomal proteins in RPE of Cib2-mutant mice could potentially be mediated via mTORC1 regulation of TFEB. If so, CIB2 overexpression might be dually beneficial, since it would reduce mTORC1 activity and thereby upregulate autophagy and lysosomal biogenesis - promising topics for further basic or translational studies.
Developing translational models to study autophagy deficits is imperative to enable the evaluation of rational treatments for AMD. Patients with dry AMD, in particular, have little to no treatment options, although the AREDS (Age-Related Eye Disease Study) nutritional supplementation formula, with carotenoids, vitamins, zinc, and copper, have been shown to have a modest effect on progression to neovascular AMD. Bypassing the RPE visual cycle by supplying exogenous retinoids has been found to effectively serve as a useful therapeutic approach for certain retinal disorders64,65. The most common methodology is using a 9-cis retinoid analog that is more stable than the physiological 11-cis retinal chromophore. Upon entering the PR, 9-cis retinal can bind with opsin to create functional visual pigment. However, unbound retinals are quite cytotoxic and quickly detoxified by the liver—an issue that has been circumvented by using the less toxic oral 9-cis retinyl acetate to treat inherited blindness of childhood caused by RPE65 and LRAT mutations66. We have found that Cib2KO RPE contains abundant large lipid-filled vacuoles and sub-retinal deposits, which may impede RPE transport mechanisms including those that deliver retinoids back to the PR, leading to reduced ERG amplitudes, even without gross PR damage. Supporting this idea, we found that providing exogenous retinoids improved ERGs in two different treatment paradigms in two different mouse models, thus providing a preclinical proof-of-concept for use of retinoids to treat AMD.
Animals, tissue harvest, and processing
The ARRIVE guidelines for reporting animal research were used for procedures involving animals. All animal studies were conducted according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and after approval from the IACUC (Institutional Animal Care and Use Committees) of the University of Maryland School of Medicine. Cib2tm1a mice (designated CIB2KO) were purchased from EUCOMM and have been validated previously18,53. To generate floxed allele (Cib2flox), Cib2tm1a were crossed ROSA26::FLPe knock in mice (Jax lab, stock#003946), which resulted in the removal of LacZ-neomycin selection cassette by Flp-FRT recombination. RPE-specific Cre-expressing mice were described earlier21, and were generously shared with us by Drs. Sheldon Miller, National Eye Institute and Joshua Duniaef from University of Pennsylvania. Previous research pointed out that these mice may develop Cre-mediated age-dependent RPE pathology67, hence for all experiments we used Cib2+/+; RPE-Cre+ mice as controls. Rod photoreceptor-specific Cre-expressing mice20 were purchased from Jackson Labs. Previous studies and our own studies have not shown any Cre-mediated toxicity in this line, hence for controls we used a mix of Cib2flox/flox or Cib2flox/+; Cre-, and Cib2+/+; Cre + mice. Mice were housed under a strict 12:12 h light on/off cycle and fed standard mouse diet (after weaning) and water ad libitum. Mice were euthanized by CO2 asphyxiation followed by cervical dislocation before immediate eye enucleation. Eyes were immersion-fixed in 2% PFA + 2% glutaraldehyde for morphometry and TEM.
RPE flat mounts were generated by first removing the anterior segment and lens from an eye, and then removing the retina carefully in Hank’s balanced salt solution (HBSS). After fixing the eyecup in 4% PFA in PBS for 30 min to 1 h, radial cuts were made to flatten the eyecup, and antibody/dye labeling was performed for fluorescence microscopy. For immunoblots, RPE/choroid tissues were snap-frozen on dry ice before storing at −80 °C before lysis. For retinoid analysis, mice were dark-adapted overnight, and dissections were performed under dim red light. For autophagy flux assay, whole mounts of RPE/choroid tissues were incubated in DMSO (control) or 50 nM Bafilomycin A1 overnight in DMEM at 37 °C before rinsing with PBS, tap drying on filter paper, followed by snap-freezing on dry ice and storing at 80 °C. Finally, for assessing mTORC1 activity following increased autophagy in vivo, mice were fasted with unlimited access to water for 24 h, followed by RPE/choroid dissection as above.
Morphometric analysis of the outer retina
Plastic sections were prepared as previously described68. Eyes were hemisected from the pupil through the optic nerve and the eyecups harvested, dehydrated in ascending ethanol concentrations, infiltrated, and embedded in JB-4 Plus resin (Ted Pella, Redding, CA). Sections 4 µm thick were cut on a Leica EMUC6 Ultramicrotome (Leica Microsystems, Buffalo Grove, IL), mounted on slides, dried, and stained with 1% cresyl violet (Sigma, St. Louis, MO). Sections were examined at ×40 or ×100 using a NIKON EFD-3 Episcopic-Fluorescence microscope (Nikon Inc., Melville, NY). Photomicrographs were taken using a Moticam 2500 high-resolution camera (Motic, British Columbia, Canada), and brightness and contrast adjusted as needed using Adobe Photoshop (Adobe Systems, San Jose, CA).
To measure the thicknesses of outer retina layers, a vertical line was drawn from the outer plexiform layer (OPL) to the RPE, and the OPL, outer nuclear layer (ONL), PR OS, and distances of inner segment (IS) edges measured individually from this line using Moticam Image Plus 2.0 Software (Motic China Group Co., Ltd., Xiamen, China), in 10 sections per eye, and overall means calculated. Retinal thickness was measured without knowledge of the genotype by a masked observer (PAS).
Transmission electron microscopy
Sections for EM were prepared as previously described68. Briefly, hemisected eyecups were rinsed in buffer and postfixed in 2% osmium tetroxide and 1.5% potassium ferrocyanide in dH2O for 2 h, dehydrated in a graded ethanol series, and embedded in Epon-Araldite (Electron Microscopy Sciences, Hatfield, PA). Semi-thin sections (4 μm) were cut and stained with 1% cresyl violet. Ultra-thin sections (90 nm) were cut on an ultramicrotome (Ultracut E 701704, Reichert-Jung, Buffalo, NY) using a diamond knife (Micro Star Technologies, Inc., Huntsville, TX), collected on copper grids, counterstained with 4% methanolic uranyl acetate (Electron Microscopy Sciences, Hatfield, PA), and outer retinal morphology examined using a transmission electron microscope (TEM; Model 300: Phillips, Eindhoven, The Netherlands). Photomicrographs were captured with a digital camera (15-megapixel digital camera, Scientific Instruments and Applications, Duluth, GA) and Maxim DL Version 5 software (Diffraction Limited, Ottawa, Canada).
Electroretinograms (ERG) were recorded as earlier described3 with modifications. Mice, overnight dark-adapted, were anesthetized with ketamine-xylazine (100 and 10 mg/kg, respectively) and pupils were dilated with 1% Tropicamide. A gold wire lens electrode was placed on the cornea, a platinum reference electrode in the mouth, and a ground electrode on the tail. To assess rod-driven responses, increasing scotopic stimuli were presented sequentially (0.003962233 to 3.147314 cd × s/m2) at 5–60 s intervals using UTAS BigShot (LKC Technologies, Gaithersburg, MD). At least 3 waveforms per intensity were averaged. For cone function evaluation, photopic responses to a single bright flash (3.15 cd × s/m2) under a steady rod-suppressing field of cd × s/m2. Waves were analyzed using EM for Windows software (LKC Technologies). For 9-cis retinal treatment, animals received intraperitoneal 0.25 mg 9-cis retinal (dissolved in 100% Et-OH) in a 200 µl vehicle (10% BSA in 0.9% NaCl solution, sterile filtered) or vehicle only69, in the dark. ERGs were performed as above, the next day, or at indicated times.
Cell culture, drug treatment, synchronized cell culture phagocytosis assay
Immortalized RPE-J cells derived from rat (ATCC, Manassas, VA) were maintained at 32 °C and 8% CO2 in 4% FBS/DMEM supplemented with 1x penicillin/streptomycin. HEK-293T, COS-7, LAM-621, and TSC2KO/KO p53KO/KO MEF cells were maintained at 37 °C/5% CO2 in 10% FBS-DMEM supplemented with 1× penicillin/streptomycin. OS were purified from fresh porcine eyes harvested within 24 h from Sierra For Medical Science (Whittier, CA) using an established protocol70, modifying only the preparation of sucrose density gradient tubes. Twenty-four hours before OS purification, sucrose step gradients (20–60% in 10% increments) were prepared in ultracentrifugation tubes and frozen at −20 °C at an ~45° angle. On the day of purification, a continuous gradient was formed by thawing at room temperature at this angle. Pulse-chase experiments were performed as we described3. RPE-J cells transiently over-expressing AcGFP or CIB2-IRES-AcGFP were challenged with ~10 OS/cell in serum-free DMEM with 1 μM MFG-E8 for 1 h at 20 °C (pulse, POS binding only). After washing unbound POS with PBS, cells were chased for indicated times at 32 °C with 5% FBS-supplemented DMEM. At the end of the pulse or chase period, cells were rinsed 3x with PBS before lysis in RIPA buffer with a solution containing 1× protease inhibitors, 1 mM Na orthovanadate, 10 mM Na glycerophosphate, and 10 mM NaF, and stored at −80 °C until immunoblotting.
X-gal staining, lipid droplet, and indirect lysosome labeling
For X-gal staining, Cib2WT/WT (control) and Cib2KO/+ enucleated eyes were fixed for 1 h in 0.5% glutaraldehyde (0.5%)+NP-40 (0.02%) diluted in PBS, followed by washing with PBS 2× for 5 min. Eyes were stained overnight at 37 °C in tubes covered with aluminum foil with PBS, in a solution of 1 mg/ml X-Gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.02% NP-40, and 0.01% sodium deoxycholate. The next day, the eyes were washed once for 5 min in PBS followed by post-fixation with 2% PFA – 2% glutaraldehyde in PBS for at least 1 h at RT. An opening was made in the lens region to allow OCT penetration and embedding. 20–30 µm thick sections were cut on a Cryotome (Leica, Germany).
Phagosome counts in whole mounts of RPE were performed using Ret-P1 antibody3. Whole-mount RPE/choroid preparations were live-stained with 1 µM BODIPY-Pepstatin A or 0.1 mg/ml BODIPY-493/503 in DMEM at 37 °C for 30 min followed by fixation with 4% PFA.
60-70% confluent COS-7 cells or RPE-J cells were fixed with 4% PFA for 15 min at RT and permeabilized with 0.2% Triton X-100 in PBS (15 min), followed by blocking with 10% normal goat serum (NGS) in PBS for at least 30 min at RT. Primary antibodies were diluted in 3% NGS-PBS and incubated overnight at 4 °C, followed by incubations with the indicated goat secondary antibodies. Phalloidin-647 or rhodamine-phalloidin was added at dilutions of 1:1000 (COS-7) or 1:200 (RPE-J) during secondary antibody incubation to stain F-actin. A Zeiss-710 laser scanning confocal microscopy system was used for image acquisition, with a step size of 0.5 µm. Fiji (ImageJ)71 was used to process images, and average numbers of phagosomes per 100 µm2 of the retina were calculated [detailed in ref. 30]. For counting area of undigested material or mitochondria as control (Fig. 2c, d), outlines were drawn in Fiji on TEM images from indicated genotypes of mice sacrificed 8 h after light onset, and areas calculated using Fiji functions.
Filipin and Oil red O staining
Ten-micron cryosections were prepared using standard procedures and filipin staining for esterified cholesterol (EC) and unesterified cholesterol (UC) was performed29. For oil Red O staining, cryosections were dipped in 60% isopropanol for 5 seconds, followed by incubation for 15 min at RT in working solution of Oil Red O (3 parts:2 parts::0.5% Oil Red O solution in isopropanol:water, the working solution was mixed and allowed to stand for 10 min before filtration with vacuum filtration system containing 0.22 µm filter). The slides were then dipped in 60% isopropanol 5 times to remove excess stain and dipped in distilled water 10 times. The imaging was performed with a ×100 objective.
Cell culture, transfection, and nanoSPD
We optimized the following protocol for 24 wells RPE-J cells transfection using Lipofectamine-2000: Lipofectamine-2000:DNA (2–4 µg plasmid/well)::3:1 was prepared in 100 µl Optimem. Although, the very high plasmid concentration leads to toxicity for most other cell types but works well for RPE-J cells. Cells were used for transfection at ~70% confluence. The medium was replaced with 400 µl Optimem/well (adding Optimem instead of 2% FBS-DMEM is important for transfecting RPE-J cells). The Lipofectamine/plasmid mix was added dropwise. Twenty-four hours later the medium was changed to complete medium (4% FBS-DMEM), and cells were allowed to grow/express plasmid for a further 24 h before fixing or used for pulse-chase experiments, followed by immunoblotting. This method reliably and reproducibly gave us >60% transfection.
A total of 60–70% confluent COS-7 cells in 6-well plates for nanoTRAP were transfected with Lipofectamine-2000 (3:1 ratio) with 1 µg plasmid construct each (nanoTRAP, GFP-tagged bait, and prey). Twenty-four hours after transfection, cells were split 1:10 ratio on glass coverslips to allow for filopodia formation, and fixed 24 h later with 4% PFA for 15 min at RT and permeabilized with 0.2% Triton X-100 in PBS for 15 min at RT, followed by blocking with 10% normal goat serum (NGS) in PBS for at least 30 min at RT. Primary antibodies were diluted in 3% NGS-PBS and incubated overnight at 4 °C, followed by incubations with the indicated goat secondary antibodies. A Zeiss-710 laser scanning confocal microscope or Nikon W1 spinning disk microscope was used for image acquisition, with a step size of 0.5 µm. Fiji (ImageJ)71 was used to process images. Finally, LAM-621 and TSC2−/−, p53−/− MEFs were transfected with Lipofectamine-2000 following the manufacturer’s instructions.
Co-immunoprecipitation, immunoblotting, and mTOR kinase assay
A total of 80% of confluent HEK293 cells in 10-cm dishes were transfected for co-IP experiments with 10 µg of indicated plasmid/s using the polyethylenimine (PEI) method (3:1::PEI:DNA). 2 plates per condition were used. Thirty-six hours later the plates were chilled on ice, washed once with ice-cold PBS, and cells collected in ice-cold PBS and centrifuged for 2 min at 211×g at 4 °C. Cell pellet was then lysed in IP buffer (0.3% CHAPS, 40 mM HEPES, 2.5 mM MgCl2, 1× Protease inhibitors, 1 mM Na orthovanadate, 10 mM Na glycerophosphate, 10 mM NaF) on ice for 20 min, followed by centrifuging at full speed for 20 min at 4 °C. Lysates were pre-cleared with control agarose beads for 1 h rotating at 4 °C. 30 µl of a 50% slurry of either HA or GST beads washed three times in lysis buffer was added. Samples were rotated 3 h or overnight at 4 °C, washed four times in IP buffer, boiled in 50–100 µl SDS sample buffer at 95 °C, separated by SDS-gel electrophoresis, transferred to PVDF membranes, and immunoblotted.
For GTPγS or GDP loading experiments, cleared lysates of HEK293 cells over-expressing HA-GST-Rheb were prepared as described in IP buffer lacking MgCl2. Rheb was immobilized on GST beads by incubating for 2 h, rotating at 4 °C. Beads were washed 4 times with IP buffer without MgCl2. GTPγS or GDP was added to final concertation of 100 µM and 1 mM, respectively. The tubes were incubated with shaking for 1 h at 37 °C. Loading was stopped by placing tubes on ice and adding MgCl2 to final concentration of 60 mM. TdTomato (control) or tdTomato-CIB2 cleared lysates were prepared as above (in IP buffer) and dividing equally to GTPγS of GDP-loaded Rheb and incubated with rotation overnight. The next day, the beads were washed, processed, and immunoblotted as above. For mTOR kinase assays, Cib2WT/WT or Cib2KO/KO animals, were starved for 24 h with regular access to water, to induce mTORC1 activation. The brains were lysed in IP buffer, cleared and mTORC1 was immunoprecipitated using Raptor antibody or rabbit IgG as control. The beads were washed with IP buffer and then kinase buffer twice, and processed as detailed in previously37 using 6×His-4E-BP-1.
Adipose-derived mesenchymal stem cells isolation (MSC), expansion, and culturing
MSCs were isolated as described72 with some modifications. Briefly, WT and Cib2KO/KO (n = 3–4/genotype) adipose tissue was dissected from a subcutaneous site of mice at 9 months of age, thoroughly washed with several changes of PBS to remove blood vessels, hairs, and other types of connective tissues, and minced. The minced samples were incubated with the collagenase I solution (10 mg solution in DMEM/3 gm tissue) for 40 min at 37 °C with shaking. After digestion, the sample was diluted 1:1 in culture medium (DMEM supplemented with 15 % FBS and 1×Pen-Strep) and filtered to further disintegrate aggregates. The resulting filtrate was centrifuged at 211×g for 10 min, and resulting pellets were re-suspended in 1 ml culture medium and plated the isolated stromal vascular fraction (SVF: consisted of MSC along with circulating blood cells, fibroblasts, pericytes, and endothelial cells) in T-25 culture flasks coated with 1% gelatin. WT and mutant MSCs were grown in 6-well plates on coverslip, for amino acid, insulin, and glucose stimulation experiments, cells were processed as described37.
Retinoid extraction and analysis
All procedures were performed under red safelights. For analysis of mouse ocular retinoids, mouse eye tissues (retinae or eyecups) were homogenized in 1 ml of freshly made hydroxylamine buffer (50 mM MOPS, 10 mM NH2OH, pH 6.5). After the addition of 1 ml ethanol, samples were mixed, then incubated for 30 min in the dark at RT. Retinoids were extracted into hexane (2 × 4 ml) then the solvent was evaporated under a gentle stream of argon at 37 °C. The dried samples were re-dissolved in a 50 μl mobile phase for analysis. Retinaloxime73 and retinyl palmitate (Sigma Aldrich, Saint Louis, MO) standards, and samples were separated on a 5 μm LiChrospher Si-60 (ES Industries, West Berlin, NJ) normal-phase column on a Waters H-Class Acquity UPLC (Waters Corp., Milford, MA, USA) in hexane mobile phase containing ethyl acetate (11.2%):dioxane (2.0%):octanol (1.4%) at a flow rate of 1.5 ml/min. Absorbance was monitored at 325 nm for retinyl esters and 350 nm for retinaloximes. Peak areas were integrated and quantified using calibration curves based on external standards. Data were analyzed using Empower 3 software (Waters Corp.).
A2E extraction and analysis
Pairs of mouse eyes from individual mice were homogenized in 975 µl H2O and 2.5 ml methanol–glacial acetic acid (98:2), followed by the addition of 1.125 ml chloroform to get a single-phase solution. The solution was thoroughly mixed and centrifuged for 5 min at 21,130×g to pellet proteins. Then 1.225 ml of chloroform and 1.225 ml of H2O were added, the tube was mixed for 1 min to separate into two phases and the lower organic phase containing A2E was collected. The solvent was evaporated, and the residue dissolved in acetonitrile (ACN) for analysis. A2E was analyzed by reversed-phase HPLC on a Waters Acquity H-Class UPLC system equipped with an Acquity UPLC BEH C18 column (1.7 μm particles; 2.1 × 50 mm) using isocratic elution with 0.1% trifluoroacetic acid in 20% H2O/80% ACN at 1.2 ml/min. Specific wavelength detection was used for monitoring A2E (430 nm), and the quantities of A2E were determined from a calibration curve developed using a synthetic A2E standard. Data were analyzed using Empower 3 software (Waters Corp.).
Human AMD/ control tissue
Studies on human tissue followed the Declaration of Helsinki guidelines. Human age-matched RPE-choroid tissues were obtained from donor eyes harvested from local and national eye banks, under an IRB exemption issued by the University of Maryland-Baltimore. A complete ocular history, relevant medical history and age was obtained from each donor. Donors with dry AMD and age-matched normal donors were selected for use. We excluded donors with any eye-related diseases besides AMD, or systemic disorders that might affect retinal/RPE or choroidal function. Eyes were examined and RPE/choroidal tissue isolated by a trained Ophthalmologist (SLB) and any additional lesions noted prior to preservation. Tissues were snap-frozen on dry ice and stored at −80 °C prior to use.
For ERG analysis, four to eight animals were used per time point/genotype/treatment. For in vivo experiments, at least three mouse eyes (from different animals) were used for immunoblots, at least three images were averaged per eye from the three eyes/indicated genotype/time point for confocal microscopy. For cell culture (in vitro) experiments, at least three independent experiments or two independent experiments for co-IP studies were performed. One-way ANOVA with Tukey’s post hoc test or a student’s t-test was used to compare the control sample to test samples, with data presented as mean ± SEM. Differences with p < 0.05 were considered significant. Data were analyzed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA). Source data are provided with this paper.
Statistics and reproducibility
All experiments were performed with at least three animals for in vivo work, and three independent replicates for cell culture-based assays, unless otherwise noted.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The data supporting the findings of this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.
Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev. 85, 845–881 (2005).
Kim, J.-Y. et al. Noncanonical autophagy promotes the visual cycle. Cell 154, 365–376 (2013).
Sethna, S. et al. Regulation of phagolysosomal digestion by Caveolin-1 of the retinal pigment epithelium is essential for vision. J. Biol. Chem. https://doi.org/10.1074/jbc.M115.687004 (2016).
Valapala, M. et al. Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy 10, 480–496 (2014).
Golestaneh, N., Chu, Y., Xiao, Y.-Y., Stoleru, G. L. & Theos, A. C. Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis. 8, e2537 (2017).
Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106–e116 (2014).
Brown, G. C. et al. The burden of age-related macular degeneration: a value-based medicine analysis. Trans. Am. Ophthalmol. Soc. 103, 173–186 (2005).
Al-Zamil, W. M. & Yassin, S. A. Recent developments in age-related macular degeneration: a review. Clin. Interv. Aging 12, 1313–1330 (2017).
Choi, A. M. K., Ryter, S. W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 651–662 (2013).
Schneider, J. L. & Cuervo, A. M. Autophagy and human disease: emerging themes. Curr. Opin. Genet. Dev. 26, 16–23 (2014).
Leidal, A. M., Levine, B. & Debnath, J. Autophagy and the cell biology of age-related disease. Nat. Cell Biol. 20, 1338–1348 (2018).
Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).
Wolfson, R. L. & Sabatini, D. M. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 26, 301–309 (2017).
Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771–785 (2014).
Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552, 368 (2017).
Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012).
Riazuddin, S. et al. Mutations in CIB2, a calcium and integrin binding protein, cause Usher syndrome type 1J and nonsyndromic deafness DFNB48. Nat. Genet. 44, 1265–1271 (2012).
Giese, A. P. J. et al. CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells. Nat. Commun. 8, 43 (2017).
Barabas, P. et al. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration. Proc. Natl Acad. Sci. 110, 5181–5186 (2013).
Li, S. et al. Rhodopsin-iCre transgenic mouse line for Cre-mediated rod-specific gene targeting. Genesis 41, 73–80 (2005).
Iacovelli, J. et al. Generation of Cre transgenic mice with postnatal RPE-specific ocular expression. Investig. Ophthalmol. Vis. Sci. 52, 1378–1383 (2011).
Curcio, C. A. et al. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 81, 731–741 (2005).
Ambati, J. & Fowler, BenjaminJ. Mechanisms of age-related macular degeneration. Neuron 75, 26–39 (2012).
Abdelsalam, A., Del Priore, L. & Zarbin, M. A. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv. Ophthalmol. 44, 1–29 (1999).
Anderson, D. H. et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol. 131, 767–781 (2001).
Helgason, H. et al. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat. Genet. 45, 1371–1374 (2013).
Seddon, J. M. et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat. Genet. 45, 1366–1370 (2013).
Zhan, X. et al. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat. Genet. 45, 1375–1379 (2013).
Notomi, S. et al. Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retina. Proc. Natl Acad. Sci. USA 116, 23724–23734 (2019).
Sethna, S. & Finnemann, S. C. in Retinal Degeneration: Methods and Protocols (eds Bernhard, H. F. Weber & Langmann, T.) 245–254 (Humana Press, 2013).
Bosch, E., Horwitz, J. & Bok, D. Phagocytosis of outer segments by retinal pigment epithelium: phagosome- lysosome interaction. J. Histochem. Cytochem. 41, 253–263 (1993).
Rakoczy, P. E. et al. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am. J. Pathol. 161, 1515–1524 (2002).
Regan, C. M., de Grip, W. J., Daemen, F. J. M. & Bonting, S. L. Degradation of rhodopsin by a lysosomal fraction of retinal pigment epithelium: biochemical aspects of the visual process. XLI. Exp. Eye Res. 30, 183–191 (1980).
Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1–222 (2016).
Wyant, G. A. et al. mTORC1 activator SLC38A9 is required to efflux essential amino acids from lysosomes and use protein as a nutrient. Cell 171, 642–654.e612 (2017).
Bird, J. E. et al. Harnessing molecular motors for nanoscale pulldown in live cells. Mol. Biol. Cell 28, 463–475 (2017).
Fawal, M.-A., Brandt, M. & Djouder, N. MCRS1 binds and couples rheb to amino acid-dependent mTORC1 activation. Dev. Cell 33, 67–81 (2015).
Li, Y., Inoki, K. & Guan, K.-L. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol. Cell. Biol. 24, 7965–7975 (2004).
Tabancay, A. P. et al. Identification of dominant negative mutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6K. J. Biol. Chem. 278, 39921–39930 (2003).
Parmar, N. & Tamanoi, F. in The Enzymes Vol. 27, 39–56 (Academic Press, 2010).
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. & Avruch, J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702–713 (2005).
Kaarniranta, K. et al. Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 9, 973–984 (2013).
Yao, J. et al. Deletion of autophagy inducer RB1CC1 results in degeneration of the retinal pigment epithelium. Autophagy 11, 939–953 (2015).
Mitter, S. K. et al. Autophagy in the retina: a potential role in age-related macular degeneration. Adv. Exp. Med. Biol. 723, 83–90 (2012).
Vives-Bauza, C. et al. The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J. Biol. Chem. 283, 24770–24780 (2008).
Shields, C. L., Reichstein, D. A., Bianciotto, C. & Shields, J. A. Retinal pigment epithelial depigmented lesions associated with tuberous sclerosis complex. Arch. Ophthalmol. 130, 387–390 (2012).
Yu, J., Astrinidis, A., Howard, S. & Henske, E. P. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am. J. Physiol. 286, L694–L700 (2004).
Saari, J. C. Biochemistry of visual pigment regeneration: the Friedenwald lecture. Investig. Ophthalmol. Vis. Sci. 41, 337–348 (2000).
Wald, G. & Brown, P. K. Synthesis and bleaching of rhodopsin. Nature 177, 174–176 (1956).
Leisner, T. M., Freeman, T. C., Black, J. L. & Parise, L. V. CIB1: a small protein with big ambitions. FASEB J. 30, 2640–2650 (2016).
Vallone, R., Dal Cortivo, G., D’Onofrio, M. & Dell’Orco, D. Preferential binding of Mg(2+) over Ca(2+) to CIB2 triggers an allosteric switch impaired in usher syndrome type 1J. Front. Mol. Neurosci. 11, 274–274 (2018).
Zhu, W. et al. CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1. Cancer Res. 77, 4823–4834 (2017).
Michel, V. et al. CIB2, defective in isolated deafness, is key for auditory hair cell mechanotransduction and survival. EMBO Mol. Med. 9, 1711–1731 (2017).
Wang, Y. et al. Loss of CIB2 causes profound hearing loss and abolishes mechanoelectrical transduction in mice. Front. Mol. Neurosci. 10, 401 (2017).
Rodieck, R. W. Components of the electroretinogram—a reappraisal. Vis. Res. 12, 773–780 (1972).
Boada-Romero, E., Martinez, J., Heckmann, B. L. & Green, D. R. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/s41580-020-0232-1 (2020).
Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121–135 (2018).
Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983–997 (2013).
Petrou, P. A. et al. Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialintravitreal sirolimus for GA: Phase I/II Trial. Investig. Ophthalmol. Vis. Sci. 56, 330–338 (2015).
Gensler, G. et al. Treatment of geographic atrophy with intravitreal sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study. Ophthalmol. Retin. 2, 441–450 (2018).
Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159–168 (2006).
Mahoney, S. J. et al. A small molecule inhibitor of Rheb selectively targets mTORC1 signaling. Nat. Commun. 9, 548 (2018).
Martini-Stoica, H., Xu, Y., Ballabio, A. & Zheng, H. The autophagy–lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 39, 221–234 (2016).
Maeda, T. et al. Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate. Hum. Mol. Genet. 18, 2277–2287 (2009).
Palczewski, K. Retinoids for treatment of retinal diseases. Trends Pharmacol. Sci. 31, 284–295 (2010).
Koenekoop, R. K. et al. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial. Lancet 384, 1513–1520 (2014).
He, L., Marioutina, M., Dunaief, J. L. & Marneros, A. G. Age- and Gene-dosage–dependent Cre-induced abnormalities in the retinal pigment epithelium. Am. J. Pathol. 184, 1660–1667 (2014).
Scott, P. A., Kaplan, H. J. & Sandell, J. H. Anatomical evidence of photoreceptor degeneration induced by iodoacetic acid in the porcine eye. Exp. Eye Res. 93, 513–527 (2011).
Xue, Y. et al. CRALBP supports the mammalian retinal visual cycle and cone vision. J. Clin. Investig. 125, 727–738 (2015).
Parinot, C. et al. Large-scale purification of porcine or bovine photoreceptor outer segments for phagocytosis assays on retinal pigment epithelial cells. J. Vis. Exp. e52100, https://doi.org/10.3791/52100 (2014).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676 (2012).
Bunnell, B. A., Flaat, M., Gagliardi, C., Patel, B. & Ripoll, C. Adipose-derived stem cells: Isolation, expansion and differentiation. Methods 45, 115–120 (2008).
Garwin, G. G. & Saari, J. C. in Methods in Enzymology Vol. 316, 313–324 (Academic Press, 2000).
We thank Drs. M. Johnson, M. Matthews, and Ms. S. Riaz and D. Gomes for technical assistance; Drs. S. Miller, and J. Duniaef for mouse strains, Dr. E. Henske for cell lines, and the UMSOM core facility for access to the Zeiss-710 confocal and Nikon W1 microscopes. We also thank Drs. T.B. Friedman, R. Hertzano, C. Mueller, G. Frolenkov, and Ms. M. Ahmed for critically reading the manuscript. This work was supported by NIDCD/NIH grants R01DC012564, R01DC016295 (Z.M.A.), R56DC011803 (S.R.), and partly by the Loris Rich Postdoctoral fellowship, International Retinal Research Foundation, AL, USA (S.S.), and Research to Prevent Blindness Award (P.A.S. and Z.M.A.).
Some authors declare competing financial interests (S.S., S.R., Z.M.A.) and have filed a patent application for the CIB2 role in modulating mTORC1 signaling (PCT/US2019/044745). The remaining authors declare no competing interests.
Peer review information Nature Communications thanks Demetrios Vavvas and other, anonymous, reviewers for their contributions to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sethna, S., Scott, P.A., Giese, A.P.J. et al. CIB2 regulates mTORC1 signaling and is essential for autophagy and visual function. Nat Commun 12, 3906 (2021). https://doi.org/10.1038/s41467-021-24056-1